Skip to main content
Premium Trial:

Request an Annual Quote

Kinneret Savitsky, Dorit Bitter, Michal Preminger, Aram Adourian, Ken Olisa, Russell Singleton


Kinneret Savitsky, VP of biology R&D; Dorit Bitter, VP of computational life sciences R&D; and Michal Preminger, VP of protein therapeutics, will be leaving Compugen, the company said last week. “The three are independent incidences and have nothing to do with one another,” said a Compugen spokeswoman.

Aram Adourian has been named VP of computational sciences at Beyond Genomics. He joins the firm from the Whitehead Institute for Biomedical Research at MIT, where he was a founding member of the BioMEMS applied sciences laboratory and served as project manager for bioinformatics.

BioWisdom has appointed Ken Olisa as a non-executive director of the company. Olisa is chairman and CEO of Interregnum, a technology merchant bank that he founded in 1992.

Russell Singleton has joined Perlegen Sciences as VP of engineering and informatics. Singleton led the instrumentation and software development programs at Molecular Dynamics. More recently, as president of his own firm, he led the development of business and marketing strategies for biotechnology firms and semiconductor capital equipment companies.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.